Skip to search formSkip to main contentSkip to account menu

ramosetron

Known as: 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazol 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

AntiemeticsBenzimidazolesSerotonin Antagonists

Narrower (2)

NaseaYM 060
ramosetron hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Reevaluation of the Effectiveness of Ramosetron for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis
BACKGROUND: Ramosetron has been shown to have a very strong effect for preventing postoperative nausea and vomiting (PONV) in… 
2012
2012
Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.
2012
2012
Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential.
2010
2010
Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy.
BACKGROUND Post-operative nausea and vomiting (PONV) is common. 5HT 3 receptor antagonists are commonly used drugs for its… 
2010
2010
Effect of ramosetron on shivering during spinal anesthesia
Background Shivering associated with spinal anesthesia is uncomfortable and may interfere with monitoring. The aim of this study… 
2007
2007
Ramosetron versus Ondansetron in the Prevention of Chemotherapy-Induced Gastrointestinal Side Effects: A Prospective Randomized Controlled Study
Background: This study observed and compared the preventive effects of ramosetron and ondansetron on gastrointestinal side… 
2007
2007
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
We examined the pharmacological profile of ramosetron, a 5-HT(3)-receptor antagonist for irritable bowel syndrome with diarrhea… 
Review
2002
Review
2002
Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.
Ramosetron is a selective serotonin 5-HT3 receptor antagonist with an affinity higher than that of the previously available drugs… 
Highly Cited
1999
Highly Cited
1999
Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery.
UNLABELLED In a prospective, randomized, double-blinded study, we evaluated the efficacy of granisetron and ramosetron for… 
1998
1998
Comparative study of [3H]ramosetron and [3H]granisetron binding in the cloned human 5-hydroxytryptamine3 receptors.
Characteristics of the binding of [3H]ramosetron to cloned human 5-hydroxytryptamine3 (5-HT3) receptors were investigated and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)